Norway vs Trinidad and Tobago: Measles-containing-vaccine second-dose (MCV2) immunization coverage
Norway
95.0%
in 2025
Trinidad and Tobago
96.0%
in 2025
Norway rank
29th
Trinidad and Tobago rank
26th
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Norway
- Trinidad and Tobago
How they compare
Trinidad and Tobago currently reports 96.0% against 95.0% in Norway, a difference of 1.0%.
The two have swapped places 3 times across 26 shared years of data; in 2000 it was Norway ahead.
Norway ranks 29th and Trinidad and Tobago ranks 26th of 194 countries.
Norway has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Norway | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 91.5% | 71.8% | 19.7% | Norway |
| 2010s | 92.6% | 85.6% | 7.0% | Norway |
| 2020s | 94.5% | 91.0% | 3.5% | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Norway or Trinidad and Tobago?
- Trinidad and Tobago, at 96.0% against 95.0% in Norway as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Norway and Trinidad and Tobago?
- 1.0%, with Trinidad and Tobago ahead.
- How many years of comparable data are there for Norway and Trinidad and Tobago?
- 26 years are reported by both, from 2000 to 2025.
- How do Norway and Trinidad and Tobago rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Norway ranks 29th and Trinidad and Tobago ranks 26th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.